| 48 | | || '''14'''e || || exclusion_criteria || Y || 8000 || !ClinicalTrial || exclusion_criteria || Char(8000) || adv. || |
| 49 | | || '''15'''a || StudyTypeField || study_type || N || 255 || !ClinicalTrial || study_type || Char(255) || adv. || |
| 50 | | || '''15'''b || || study_design || N || 1000 || !ClinicalTrial || study_design || Char(1000) || basic || |
| 51 | | || '''15'''c || || phase || N || 255 || !ClinicalTrial || phase || Char(255) || adv. || |
| | 48 | || '''14'''e || || exclusion_criteria || Y || Y || 8000 || !ClinicalTrial || exclusion_criteria || Char(8000) || adv. || |
| | 49 | || '''15'''a || StudyTypeField || study_type || Y || N || 255 || !ClinicalTrial || study_type || Char(255) || adv. || |
| | 50 | || '''15'''b || || study_design || Y || N || 1000 || !ClinicalTrial || study_design || Char(1000) || basic || |
| | 51 | || '''15'''c || || phase || Y || N || 255 || !ClinicalTrial || phase || Char(255) || adv. || |
| | 52 | || || || || || || || || || || || |